T-type calcium channel blockers - New and notable

General Physiology and Biophysics

Volumn 30, Issue 4, 2011, Pages 403-409

  Lacinová, L'Ubica ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

Dihydropyridines; Phenylakylamines; T type calcium channels; Zn 2+, Cu 2+, Ni 2+, Co 2+, Cd 2+, La 3+, Er 3+, Y 3+

Indexed keywords

AMLODIPINE; BENIDIPINE; CADMIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; COBALT; CUPRIC ION; DIHYDROPYRIDINE; EFONIDIPINE; HISTIDINE; ISRADIPINE; LANTHANIDE; LANTHANUM; NICKEL; NIFEDIPINE; NIMODIPINE; PHENYLALKYLAMINE; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL; YTTRIUM; ZINC ION;

BINDING AFFINITY; BINDING SITE; IC 50; SHORT SURVEY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CATIONS; COPPER; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; NICKEL; ZINC;

EID: 83155182705     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2011_04_403     Document Type: Short Survey

References (63)

1. 2+ current of mouse spermatogenic cells. Mol. Pharmacol. 53, 1104-1111
2. Beedle A. M., Hamid J., Zamponi G. W. (2002): Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations. J. Membr. Biol. 187, 225-238 http://dx.doi.org/10.1007/s00232-001-0166- 2 (Pubitemid 34587778)
3. Bergson P., Lipkind G., Lee S. P., Duban M. E., Hanck D. A. (2011): Verapamil block of T-type calcium channels. Mol. Pharmacol. 79, 411-419 http://dx.doi.org/10.1124/mol.110.069492
4. Bleakman D., Bowman D., Bath C. P., Brust P. E, Johnson E. C., Deal C. R., Miller R. J., Ellis S. B., Harpold M. M., Hans M., et al. (1995): Characteristics of a human N-type calcium channel expressed in HEK293 cells. Neuropharmacology 34, 753-765 http://dx.doi.org/10.1016/0028-3908(95)00078-K
5. Brown G. R., Fraser D. G., Castile J. A., Gaudreault P., Platt D. R., Friedman P. A. (1986): Nifedipine serum concentrations following sublingual and oral doses. Int. J. Clin. Pharmacol. Ther. Toxicol. 24, 283-286 (Pubitemid 16084155)
6. Caro A., Tarabova B., Rojo-Ruiz J., Lacinova L. (2011): Nimodipine inhibits AP firing in cultured hippocampal neurons predominantly due to block of voltage-dependent potassium channels. Gen. Physiol. Biophys. 30 (Special Issue), S44-53
7. V3.3 gating kinetics: implications for thalamocortical activity. J. Neurophysiol. 98, 2274-2284 http://dx.doi.org/10. 1152/jn.00889.2006
8. v3 channels. J. Membr. Biol. 207, 91-105 http://dx.doi.org/10.1007/s00232-005-0804-1
9. Drigelova M., Tarabova B., Duburs G., Lacinova L. (2009): The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents. Can. J. Physiol. Pharmacol. 87, 923-932 http://dx.doi.org/10.1139/Y09- 086
10. Ertel E. A., Campbell K. P., Harpold M. M., Hofmann F., Mori Y., Perez-Reyes E., Schwartz A., Snutch T. P., Tanabe T., Birnbaumer L., Tsien R. W., Catterall W. A. (2000): Nomenclature of voltage-gated calcium channels. Neuron 25, 533-535 http://dx.doi.org/10.1016/S0896-6273(00)81057-0
11. Fan J. S., Palade P. (1999): One calcium ion may suffice to open the tetrameric cardiac ryanodine receptor in rat ventricular myocytes. J. Physiol. 516, 769-780 http://dx.doi.org/10.1111/j.1469-7793.1999.0769u.x
12. Fox A. P., Nowycky M. C., Tsien R. W. (1987): Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones. J. Physiol. 394, 149-172 (Pubitemid 18005128)
13. 2+ channel. Mol. Pharmacol. 70, 718-726 http://dx.doi.org/10.1124/mol.106.023473
14. 2+ channel subtypes expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 291, 464-473
15. Furukawa T., Miura R., Honda M., Kamiya N., Mori Y., Takeshita S., Isshiki T., Nukada T. (2004): Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels. Br. J. Pharmacol. 143, 1050-1057 http://dx.doi.org/10.1038/sj.bjp.0705944 (Pubitemid 40065506)
16. 2+ channel (α1G) expressed in Xenopus oocytes. J. Cardiovasc. Pharmacol. 45, 241-246 http://dx.doi.org/10.1097/01.fjc.0000154374.88283.15
17. Gao Z., Sun H., Chiu S. W., Lau C. P., Li G. R. (2005): Effects of diltiazem and nifedipine on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes. Br. J. Pharmacol. 144, 595-604 http://dx.doi.org/10.1038/sj.bjp.0706113 (Pubitemid 40349467)
18. Hess P. (1990): Calcium channels in vertebrate cells. Annu Rev Neurosci. 13, 337-356 http://dx.doi.org/10.1146/annurev.ne.13.030190.002005
19. Hockerman G. H., Johnson B. D., Scheuer T., Catterall W. A. (1995): Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. J. Biol. Chem. 270, 22119-22122 http://dx.doi.org/10.1074/jbc.270.38. 22119
20. Hoon T. J., McCollam P. L., Beckman K. J., Hariman R. J., Bauman J. L. (1992): Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects. Am. J. Cardiol. 70, 1072-1076 http://dx.doi.org/10.1016/0002-9149(92)90363-4
21. 2+ channel blockers. Life Sci. 82, 554-560 http://dx.doi.org/10.1016/j.lfs.2007.11.010
22. Iftinca M. C., Zamponi G. W. (2009): Regulation of neuronal T-type calcium channels. Trends Pharmacol. Sci. 30, 32-40 http://dx.doi.org/10.1016/j. tips.2008.10.004
23. 2+ channel blocker. Life Sci. 88, 898-907 http://dx.doi.org/10.1016/j.lfs.2011.03. 019
24. Jeong S. W., Park B. G., Park J. Y., Lee J. W., Lee J. H. (2003): Divalent metals differentially block cloned T-type calcium channels. Neuroreport 14, 1537-1540 http://dx.doi.org/10.1097/00001756-200308060-00028
25. Johnson B. D., Hockerman G. H., Scheuer T., Catterall W. A. (1996): Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines. Mol. Pharmacol. 50, 1388-1400 (Pubitemid 26384878)
26. v3.2 T-type calcium channels. J. Biol. Chem. 281, 4823-4830 http://dx.doi.org/10.1074/jbc.M510197200
27. v3.2 T-type calcium channels. J. Biol. Chem. 285, 3271-3281 http://dx.doi.org/10.1074/jbc.M109.067660
28. v3.3 channel is determined by the gating brake in the I-II loop. Pflugers Arch. 461, 461-468 http://dx.doi.org/10.1007/s00424-011-0937-2
29. V3.1 channel affects amplitude but not voltage dependence of gating current. Gen. Physiol. Biophys. 29, 419-423 http://dx.doi.org/10.4149/gpb-2010-04-419
30. 2+ channels in rat aorta smooth muscle cells in primary culture. Circ. Res. 67, 469-480
31. Lacampagne A., Gannier F., Argibay J., Garnier D., Le Guennec J. Y. (1994): The stretch-activated ion channel blocker gadolinium also blocks L-type calcium channels in isolated ventricular myocytes of the guinea-pig. Biochim. Biophys. Acta 1191, 205-208 http://dx.doi.org/10.1016/0005-2736(94)90250-X (Pubitemid 24133546)
32. Lacinova L. (2004): Pharmacology of recombinant low-voltage activated calcium channels. Curr. Drug Targets CNS Neurol. Disord. 3, 105-111 http://dx.doi.org/10.2174/1568007043482543
33. Lacinova L., Klugbauer N., Hofmann F. (2000): Regulation of the calcium channel α1G subunit by divalent cations and organic blockers. Neuropharmacology 39, 1254-1266 http://dx.doi.org/10.1016/S0028-3908(99)00202-6 (Pubitemid 30173189)
34. v3.1 calcium channel. FEBS Lett. 531, 235-240 http://dx.doi.org/10. 1016/S0014-5793(02)03509-3
35. Lacinova L., Ludwig A., Bosse E., Flockerzi V., Hofmann F. (1995): The block of the expressed L-type calcium channel is modulated by the β3 subunit. FEBS Lett. 373, 103-107 http://dx.doi.org/10.1016/0014-5793(95)01013-5
36. Lefevre I. A., Coulombe A., Coraboeuf E. (1991): The calcium antagonist D600 inhibits calcium-independent transient outward current in isolated rat ventricular myocytes. J Physiol. 432, 65-80
37. Lin S., Wang Z., Fedida D. (2001): Influence of permeating ions on Kv1.5 channel block by nifedipine. Am. J. Physiol. Heart Circ. Physiol. 280, H1160-1172
38. 2+ channels in mouse spermatogenic cells. J. Membr. Biol. 227, 87-94 http://dx.doi.org/10.1007/ s00232-008-9148-y
39. Mathie A., Sutton G. L., Clarke C. E., Veale E. L. (2006): Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol. Ther. 111, 567-583 http://dx.doi.org/10.1016/j. pharmthera.2005.11.004 (Pubitemid 44118429)
40. Mlinar B., Enyeart J. J. (1993): Block of current through T-type calcium channels by trivalent metal cations and nickel in neural rat and human cells. J. Physiol. 469, 639-652 (Pubitemid 23281600)
41. Nelson M. T., Joksovic P. M., Su P., Kang H. W., Van Deusen A., Baumgart J. P., David L. S., Snutch T. P., Barrett P. Q., Lee J. H., Zorumski C. F., Perez-Reyes E., Todorovic S. M. (2007a): Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J. Neurosci. 27, 12577-12583 http://dx.doi.org/10.1523/JNEUROSCI.2206-07.2007 (Pubitemid 350127806)
42. Nelson M. T., Woo J., Kang H. W., Vitko I., Barrett P. Q., Perez-Reyes E., Lee J. H., Shin H. S., Todorovic S. M. (2007b): Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J. Neurosci. 27, 8250-8260 http://dx.doi.org/10.1523/JNEUROSCI.1800- 07.2007 (Pubitemid 47219607)
43. 2+ enhances the intrinsic bursting activity of a rat thalamic relay neuron. Neurosci. Res. 67, 95-97 http://dx.doi.org/10.1016/j.neures.2010.01.008
44. 2+ channels in a rat thalamic relay neuron. Neurosci. Res. 66, 353-358 http://dx.doi.org/10.1016/j. neures.2009.12.005
45. 2+ channel. J. Gen. Physiol. 124, 631-640 http://dx.doi.org/10.1085/ jgp.200409167
46. V3.1 (α1G) T-type calcium channels. J. Gen. Physiol. 132, 239-250 http://dx.doi.org/10.1085/jgp.200809988
47. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J. Pharmacol. Exp. Ther. 328, 621-627 http://dx.doi.org/10.1124/jpet.108.145672
48. Richelle M., Sabatier M., Steiling H., Williamson G. (2006): Skin bioavailability of dietary vitamin E, carotenoids, polyphenols, vitamin C, zinc and selenium. Br. J. Nutr. 96, 227-238 http://dx.doi.org/10.1079/BJN20061817 (Pubitemid 46476322)
49. + channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation. Br J Pharmacol. 131, 1275-1284 http://dx.doi.org/10.1038/sj.bjp.0703723
50. Rybalchenko V., Prevarskaya N., Van Coppenolle F., Legrand G., Lemonnier L., Le Bourhis X., Skryma R. (2001): Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating. Mol. Pharmacol. 59, 1376-1387 (Pubitemid 32510101)
51. Saito T., Fujii K., Takizawa T., Toyosaki T., Kuwabara Y., Kobayashi S., Ichikawa H., Karaki A., Yamazaki Y., Iwata J., Yamada K., Tomiya H., Takeda K., Inagaki Y. (1996): Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina. Arzneimittelforschung 46, 861-867 (Pubitemid 26312574)
52. Schuster A., Lacinova L., Klugbauer N., Ito H., Birnbaumer L., Hofmann F. (1996): The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines. Embo. J. 15, 2365-2370 (Pubitemid 26156562)
53. 2+ sensitivity of high- and low-voltage activated calcium channels. Biophys. J. 93, 1175-1183 http://dx.doi.org/10.1529/biophysj.106.103333
54. Talavera K., Nilius B. (2006): Evidence for common structural determinants of activation and inactivation in T-type Ca2+ channels. Pflugers Arch. 453, 189-201 http://dx.doi.org/10.1007/s00424-006-0129-7 (Pubitemid 44630453)
55. Tanaka H., Namekata I., Ogawa T., Tsuneoka Y., Komikado C., Takahara A., Iida-Tanaka N., Izumi-Nakaseko H., Tsuru H., AdachiAkahane S. (2010): Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(v)1 2, Ca(v)1 3 and Ca(v)3 1. Eur. J. Pharmaco. 649, 263-267 http://dx.doi.org/10.1016/j.ejphar.2010.09.014
56. Traboulsie A., Chemin J., Chevalier M., Quignard J. F., Nargeot J., Lory P. (2007): Subunit-specific modulation of T-type calcium channels by zinc. J Physiol. 578, 159-171 http://dx.doi.org/10.1113/jphysiol.2006.114496 (Pubitemid 44971117)
57. Triggle D. J. (2007): Calcium channel antagonists: clinical uses - past, present and future. Biochem. Pharmacol. 74, 1-9 http://dx.doi.org/10.1016/j.bcp. 2007.01.016
58. Tsien R. W., Lipscombe D., Madison D. V., Bley K. R., Fox A. P. (1988): Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 11, 431-438 http://dx.doi.org/10.1016/0166-2236(88)90194-4
59. Wakamori M., Strobeck M., Niidome T., Teramoto T., Imoto K., Mori Y. (1998): Functional characterization of ion permeation pathway in the N-type Ca2+ channel. J. Neurophysiol. 79, 622-634 (Pubitemid 28095882)
60. Watanabe K., Ochiai Y., Washizuka T., Inomata T., Miyakita Y., Shiba M., Izumi T., Shibata A., Qu Y. L., Nagatomo T. (1996): Clinical evaluation of serum amlodipine level in patients with angina pectoris. Gen. Pharmacol. 27, 205-209 http://dx.doi.org/10.1016/0306-3623(95)02022-5 (Pubitemid 26129181)
61. Wegener J. W., Nawrath H. (1995): Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes. Naunyn Schmiedebergs Arch. Pharmacol. 352, 322-330 http://dx.doi.org/10.1007/BF00168564
62. Williams M. E., Washburn M. S., Hans M., Urrutia A., Brust P. F., Prodanovich P., Harpold M. M., Stauderman K. A. (1999): Structure and functional characterization of a novel human low-voltage activated calcium channel. J. Neurochem. 72, 791-799 http://dx.doi.org/10.1046/j.1471-4159.1999.0720791.x (Pubitemid 29055245)
63. Zhou L. X., Finley D. K., Hassell A. E., Holtzman J. L. (1995): Pharmacokinetic interaction between isradipine and lovastatin in normal, female and male volunteers. J. Pharmacol. Exp. Ther. 273, 121-127